Perioperative Nutritional Changes Predict Adjuvant S-1 Dose Intensity in Resectable Pancreatic Cancer
HIROO SUTO, AN FUJITA, HIBIKI SAKAI, MARIN MURAMATSU, RYOSUKE WAKAMATSU, AYAKA WAKAMATSU, MIKI KATSURAGAWA, MITSUGU TANAYA, KAZUYA HIURA · 2026
Read Perioperative Nutritional Changes Predict Adjuvant S-1 Dose Intensity in Resectable Pancreatic Cancer by HIROO SUTO, AN FUJITA, HIBIKI SAKAI, MARIN MURAMATSU, RYOSUKE WAKAMATSU, AYAKA WAKAMATSU, MIKI KATSURAGAWA, MITSUGU TANAYA, KAZUYA HIURA (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13531128.txt.
Description
Hiroo Suto and co-authors study nutrition and chemo dose in pancreatic cancer in 2026. After surgery, patients take a drug to cut the chance of return, and keeping the dose high matters. What drives dose cuts is still unclear.
Records for sixty-nine patients who had prior chemo, surgery, and then the drug were reviewed. Patients who kept at least four-fifths of the dose lived longer without return. Two nutrition scores were higher in that group when the drug phase began. Shifts in those scores from the start of care also favored the high-dose group, marking nutrition as a lever.
Catalog record
| CREATOR | HIROO SUTO, AN FUJITA, HIBIKI SAKAI, MARIN MURAMATSU, RYOSUKE WAKAMATSU, AYAKA WAKAMATSU, MIKI KATSURAGAWA, MITSUGU TANAYA, KAZUYA HIURA |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |